Search results
Results from the WOW.Com Content Network
In February 2013, Tokyo court and Elpida creditors approved an acquisition by Micron Technology. [13] The company became a fully owned subsidiary of Micron Technology on July 31, 2013. [14] Effective February 28, 2014, Elpida changed its name to Micron Memory Japan and Elpida Akita changed its name to Micron Akita, Inc. [3]
Micron Technology just cemented its recent gains with an impressive fourth-quarter report. Shares prices have tripled over the last year, and this is exactly where the stock belongs. The memory ...
In 2002 Kingston launched a patented memory tester and a new HyperX line of high-performance memory modules, and also patented EPOC chip-stacking technology. In August of that year, Kingston made a $50 million investment in Elpida and launched a green initiative for module manufacturing. In 2004, Kingston announced revenues of $1.8B for 2003.
This glossary of biology terms is a list of definitions of fundamental terms and concepts used in biology, the study of life and of living organisms.It is intended as introductory material for novices; for more specific and technical definitions from sub-disciplines and related fields, see Glossary of cell biology, Glossary of genetics, Glossary of evolutionary biology, Glossary of ecology ...
A neural substrate is a term used in neuroscience to indicate the part of the central nervous system (i.e., brain and spinal cord) that underlies a specific behavior, cognitive process, or psychological state.
Acquired characteristics, by definition, are characteristics that are gained by an organism after birth as a result of external influences or the organism's own activities which change its structure or function and cannot be inherited.
Biology [ edit ] Spontaneous generation – a principle regarding the spontaneous generation of complex life from inanimate matter, which held that this process was a commonplace and everyday occurrence, as distinguished from univocal generation, or reproduction from parent(s).
Further, we completed the acquisition of three Catalent sites. And during the year, we progressed our R&D pipeline, including obesity projects, such as CagriSema and amycretin.